ClariVest Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-122
Closed -$1K 728
2022
Q4
$1K Hold
122
﹤0.01% 597
2022
Q3
$1K Sell
122
-68,700
-100% -$477K ﹤0.01% 579
2022
Q2
$574K Buy
+68,822
New +$962K 0.03% 357
2022
Q1
Sell
-235,194
Closed -$6.51M 721
2021
Q4
$6.51M Sell
235,194
-34,350
-13% -$920K 0.2% 97
2021
Q3
$7.51M Buy
+269,544
New +$7.64M 0.24% 88

Other funds holding BHC

ClariVest Asset Management's BHC Position: Q1 2023 in Review

ClariVest Asset Management sold out of Bausch Health (BHC) in Q1 2023, closing a stake of 122 shares — an estimated $1K sold.

ClariVest Asset Management first reported a position in BHC in Q3 2021 and held it in 5 quarters. The position peaked at $7.51M in Q3 2021. 235 funds tracked by Wall St. Rank hold BHC as of Q1 2023.

  • ClariVest Asset Management reported no remaining Bausch Health position as of Q1 2023 after selling out during the quarter.
  • ClariVest Asset Management sold 122 Bausch Health shares in Q1 2023, an estimated $1K.
  • ClariVest Asset Management first reported a position in Bausch Health in Q3 2021 and held it in 5 quarters.
  • ClariVest Asset Management's Bausch Health position peaked at $7.51M in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Bausch Health as of Q1 2023.

Based on ClariVest Asset Management's 13F filing for Q1 2023, filed 8 May 2023.